CINA-CSpine vs qXR-PTX-PE

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA-CSpine

by Avicenna.AI

qXR-PTX-PE

by Qure.ai Technologies

AI Verdict

Both CINA-CSpine and qXR-PTX-PE are FDA-cleared AI-powered triage tools designed to enhance workflow and patient care through rapid notification in emergency and radiology settings. However, CINA-CSpine specializes in detecting acute cervical spine fractures on neck CT scans, while qXR-PTX-PE focuses on identifying pneumothorax and pleural effusion on adult chest X-rays. Therefore, they are not direct competitors for the same diagnostic task but rather address different critical conditions within similar clinical environments.

Choose CINA-CSpine if…

Choose CINA-CSpine if your primary concern is the rapid and accurate identification of acute cervical spine fractures from non-enhanced neck CT scans. This tool is ideal for emergency departments and radiology practices needing to quickly triage and prioritize patients with potential spinal injuries, thereby enhancing diagnostic accuracy and patient care in critical situations.

View CINA-CSpine →

Choose qXR-PTX-PE if…

Choose qXR-PTX-PE if your facility requires an AI-powered solution for the immediate detection and notification of pneumothorax and pleural effusion on adult chest X-rays. This tool is best suited for critical care and emergency settings where expediting the diagnosis of these acute respiratory conditions is crucial for workflow prioritization and timely patient intervention.

View qXR-PTX-PE →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA-CSpine	qXR-PTX-PE
Pricing	Subscription	Contact for pricing
Deployment	Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Cloud-based or on-premise.
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

qXR-PTX-PE

Tool B (qXR-PTX-PE) explicitly states an average processing time of 10 seconds for alerts, which is considerably faster than Tool A's (CINA-CSpine) reported 1-10 minutes processing time. Additionally, Tool B offers multilingual support, enhancing its usability in diverse healthcare environments. Both tools emphasize seamless integration with existing workflows and PACS/RIS systems.

Clinical Value

qXR-PTX-PE

Both tools are FDA-cleared and demonstrate strong clinical value in their respective domains. However, Tool B (qXR-PTX-PE) provides slightly higher reported accuracy metrics, with up to 96% sensitivity and 100% specificity for pneumothorax and pleural effusion. Tool A (CINA-CSpine) shows impressive results with 90.3% sensitivity and 91.9% specificity for cervical spine fractures, but Tool B's figures are marginally superior.

Pricing & Value

CINA-CSpine

Tool A (CINA-CSpine) offers a more transparent pricing model, stating it is a subscription based on the number of installations and users. In contrast, Tool B (qXR-PTX-PE) requires direct contact for pricing and indicates enterprise-level licensing, which provides less upfront clarity on cost structure.

Enterprise Readiness

CINA-CSpine

Both tools are FDA-cleared, HIPAA compliant, and offer flexible deployment options (cloud/on-premise). However, Tool A (CINA-CSpine) explicitly lists support for global healthcare data standards like DICOM, HL7, and FHIR, and provides more granular local deployment options including dedicated hardware and virtualized environments. This detailed specification suggests a slightly more robust and adaptable solution for diverse enterprise IT infrastructures.

Innovation

qXR-PTX-PE

While both companies are innovative in applying AI to critical medical imaging, Tool B's (Qure.ai) broader portfolio of FDA-cleared products and its receipt of a breakthrough device designation for another solution indicate a more extensive and continuously evolving innovative footprint across various medical imaging AI applications. Tool A (Avicenna.AI) also demonstrates innovation with its specific technical approach and multiple FDA clearances for other products, but Tool B's overall breadth of innovation appears wider.

Support & Docs

qXR-PTX-PE

Tool B (qXR-PTX-PE) explicitly mentions the availability of a user's manual that guides users through installation, feature usage, and configuration with medical systems. While Tool A (CINA-CSpine) mentions 'Instructions for Use', Tool B's detailed description of its documentation suggests a more comprehensive approach to user support and guidance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA-CSpine	qXR-PTX-PE
Name	CINA-CSpine	qXR-PTX-PE
Company	Avicenna.AI	Qure.ai Technologies
Primary Detection Target	Acute cervical spine fractures on non-enhanced neck CT scans	Pneumothorax and pleural effusion on adult chest X-rays
Categories	Radiology & Imaging AI, Triage & ER/ICU AI	Radiology & Imaging AI, Triage & ER/ICU AI
Specialties	Emergency Medicine, Neurosurgery, Radiology	Critical Care, Emergency Medicine, Radiology
Average Processing Time	Not specified	10 seconds for alerts

Videos

Demos, reviews, and walkthroughs featuring CINA-CSpine and qXR-PTX-PE.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these AI tools integrate into existing radiology and emergency department workflows, and what is the depth of their integration with standard EHR systems for data exchange?

CINA-CSpine integrates seamlessly with standard reading environments like PACS and RIS, supporting global healthcare data standards such as DICOM, HL7, and FHIR. It automatically flags suspected fractures and alerts radiologists through their existing systems, without requiring new viewers or changes to workflow. Similarly, qXR-PTX-PE integrates into existing standard of care workflows and PACS/workstations, acting as a passive notification system for worklist prioritization.

What are the specific clinical accuracy metrics (sensitivity, specificity) for each tool, and how do these directly translate to improved patient outcomes and diagnostic confidence in their respective clinical applications?

CINA-CSpine demonstrated an overall sensitivity of 90.3% and specificity of 91.9% for detecting cervical spine fractures on non-enhanced neck CT scans, which can lead to faster diagnosis, accelerated surgical decisions, and reduced risk of neurological damage. Qure.ai's qXR-PTX-PE boasts high clinical accuracy with up to 96% sensitivity and 100% specificity for pneumothorax and pleural effusion on adult chest X-rays, aiding in reducing diagnostic errors and expediting interpretation in critical care settings.

For an emergency medicine physician, how does each tool specifically enhance the detection and management of acute conditions relevant to their daily practice, considering the distinct pathologies addressed?

CINA-CSpine provides rapid detection and notification of acute cervical spine fractures on neck CT scans, which is crucial for prompt intervention in trauma cases and can prevent permanent neurological damage. qXR-PTX-PE offers rapid triage and notification for pneumothorax and pleural effusion on chest X-rays, enabling faster prioritization of critical cases in emergency rooms and intensive care units, thereby expediting patient care.

What is the typical implementation timeline and the expected learning curve for medical staff to effectively utilize these AI solutions within their clinical routines?

Both tools are designed for seamless integration into existing workflows, suggesting a minimal learning curve. CINA-CSpine integrates without requiring additional clicks, training, or workflow changes, making AI insights appear automatically within usual diagnostic tools. Similarly, qXR-PTX-PE is designed to integrate seamlessly into current healthcare pathways, implying a straightforward adoption process for medical staff.

For healthcare systems considering a multi-site rollout, what are the key considerations for scaling these solutions, and are customer references available from organizations with similar large-scale implementations?

CINA-CSpine has been validated on multi-center, multi-national, and multi-vendor datasets, indicating its suitability for scalable deployment across various healthcare environments. Qure.ai's qXR-PTX-PE utilizes a globally sourced training dataset and is clinically validated in multiple geographies, suggesting its capability for multi-site rollouts. Avicenna.AI's AVI platform is designed for environments ranging from single hospitals to large healthcare networks and teleradiology services.